| Sales |
51K |
| Cost of Sales |
2.11K |
| Gross Profit (Loss) |
48.89K |
| Compensation and related benefits, including stock-based compensation of $27,600 and $50,400 for the three months and $421,700 and $241,900 for the six months ended June 30, 2013 and 2012, respectively |
| Insurance and medical benefits |
4.42K |
| Research and development |
2.83K |
| Professional, legal and consulting fees, including stock-based compensation of $80,000 and $0 for the three months and $257,000 and $4,500 for the six months ended June 30, 2013 and 2012, respectively |
9.63K |
| Marketing |
0 |
| Occupancy |
91.13K |
| (Gain) on sale of fixed asset |
| Other administrative and general |
9.99K |
| Total Operating Expenses |
162.99K |
| Loss from Operations |
-114.1K |
| Inerest income |
0 |
| Interest expense, including interest to related parties of $17,394 and $17,709 for the three months and $35,166 and $35,225 for six months ended June 30, 2013 and 2012, respectively, including $10,199 of stock based compensation for the six months ended June 30, 2013. |
-220.03K |
| Change in fair value of derivative liability |
| Total Other Income (Expense) |
| Net Loss |
| Dividend on preferred stock |
-33.64K |
| Net Loss Attributable to Common Stockholders |
| Net Loss Attributable to Common Stockholders Per Share basic and diluted |
| Weighted average number of shares outstanding - Basic and diluted |
2.55B |
